达安基因(002030) - 2017年1月17日调研活动附件

Group 1: Company Overview - The company is represented by its board secretary, Zhang Bin, alongside researchers from Dongwu Securities and China Railway Baoyin Asset Management [2] Group 2: Financial Highlights - The report does not provide specific financial figures or percentages related to revenue or growth [2]